跳至主要内容
临床试验/NCT05540782
NCT05540782进行中(未招募)不适用

Prostate Cancer Survivorship and Cognitive Health (PRO-HEALTH)

Memorial Sloan Kettering Cancer Center7 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200
试验地点
7
主要终点
number of participants with co-morbid symptoms

研究概览

简要总结

The purpose of this study is to collect information that may help the researchers understand the relationship between prostate cancer survivors' experiences of cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid factors), including anxiety, depression, and insomnia. The researchers will also find out how additional things may contribute to CRCD, including social factors, the characteristics of participants' prostate cancer, and the type of cancer treatment or other medications they received.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • English-speaking
  • Age 18 years or older
  • History of histologically documented PC of any stage
  • No evidence of PC Disease

排除标准

  • <1 month since completion of surgery, radiation, chemotherapy, or ADT
  • Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other organic brain disorder
  • Score >10 indicative of dementia on Blessed Orientation Memory Concentration

结局指标

主要结局

number of participants with co-morbid symptoms

时间窗: 1 year

All participants will be evaluable as long as they have completed the PROMIS-SF v2.0 - Cognitive Function 8a.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验